Literature DB >> 24557073

Biopharmaceutical liquid formulation: a review of the science of protein stability and solubility in aqueous environments.

Jordan W Bye1, Lauren Platts, Robert J Falconer.   

Abstract

Formulation scientists employed in the biopharmaceutical industry face the challenge of creating liquid aqueous formulations for proteins that never had evolutionary pressure to be exceptionally stable or soluble. Yet commercial products usually need a shelf life of 2 years to be economically viable. The research done in this field is dominated by physical chemists who have developed theories like preferential interaction, preferential hydration and excluded volume to explain the mechanisms for the interaction between salt, small organic molecules and proteins. This review aims to translate the research findings on protein stability and solubility produced by the physical chemists and make it accessible to formulation scientists working within the biopharmaceutical industry.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24557073     DOI: 10.1007/s10529-013-1445-6

Source DB:  PubMed          Journal:  Biotechnol Lett        ISSN: 0141-5492            Impact factor:   2.461


  16 in total

1.  Protein structural dynamics at the gas/water interface examined by hydrogen exchange mass spectrometry.

Authors:  Yiming Xiao; Lars Konermann
Journal:  Protein Sci       Date:  2015-04-02       Impact factor: 6.725

Review 2.  Structure, heterogeneity and developability assessment of therapeutic antibodies.

Authors:  Yingda Xu; Dongdong Wang; Bruce Mason; Tony Rossomando; Ning Li; Dingjiang Liu; Jason K Cheung; Wei Xu; Smita Raghava; Amit Katiyar; Christine Nowak; Tao Xiang; Diane D Dong; Joanne Sun; Alain Beck; Hongcheng Liu
Journal:  MAbs       Date:  2018-12-17       Impact factor: 5.857

Review 3.  Factors affecting the physical stability (aggregation) of peptide therapeutics.

Authors:  Karolina L Zapadka; Frederik J Becher; A L Gomes Dos Santos; Sophie E Jackson
Journal:  Interface Focus       Date:  2017-10-20       Impact factor: 3.906

4.  Effects of pH and Salt Concentration on Stability of a Protein G Variant Using Coarse-Grained Models.

Authors:  Vinícius Martins de Oliveira; Vinícius de Godoi Contessoto; Fernando Bruno da Silva; Daniel Lucas Zago Caetano; Sidney Jurado de Carvalho; Vitor Barbanti Pereira Leite
Journal:  Biophys J       Date:  2018-01-09       Impact factor: 4.033

5.  The Role of Electrostatics and Folding Kinetics on the Thermostability of Homologous Cold Shock Proteins.

Authors:  Paulo Henrique Borges Ferreira; Frederico Campos Freitas; Michelle E McCully; Gabriel Gouvêa Slade; Ronaldo Junio de Oliveira
Journal:  J Chem Inf Model       Date:  2020-01-17       Impact factor: 4.956

6.  Mesodomain and Protein-Associated Solvent Phases with Temperature-Tunable (200-265 K) Dynamics Surround Ethanolamine Ammonia-Lyase in Globally Polycrystalline Aqueous Solution Containing Dimethyl Sulfoxide.

Authors:  Benjamen Nforneh; Kurt Warncke
Journal:  J Phys Chem B       Date:  2017-12-01       Impact factor: 2.991

7.  Evaluating the Effects of Hinge Flexibility on the Solution Structure of Antibodies at Concentrated Conditions.

Authors:  Marco A Blanco; Harold W Hatch; Joseph E Curtis; Vincent K Shen
Journal:  J Pharm Sci       Date:  2018-12-26       Impact factor: 3.534

8.  Assessment of Therapeutic Antibody Developability by Combinations of In Vitro and In Silico Methods.

Authors:  Adriana-Michelle Wolf Pérez; Nikolai Lorenzen; Michele Vendruscolo; Pietro Sormanni
Journal:  Methods Mol Biol       Date:  2022

9.  Electrostatic interaction optimization improves catalytic rates and thermotolerance on xylanases.

Authors:  Vinícius de Godoi Contessoto; Felipe Cardoso Ramos; Ricardo Rodrigues de Melo; Vinícius Martins de Oliveira; Josiane Aniele Scarpassa; Amanda Silva de Sousa; Letıcia Maria Zanphorlin; Gabriel Gouvea Slade; Vitor Barbanti Pereira Leite; Roberto Ruller
Journal:  Biophys J       Date:  2021-04-05       Impact factor: 3.699

10.  Stability of a high-concentration monoclonal antibody solution produced by liquid-liquid phase separation.

Authors:  Jack E Bramham; Stephanie A Davies; Adrian Podmore; Alexander P Golovanov
Journal:  MAbs       Date:  2021 Jan-Dec       Impact factor: 5.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.